Literature DB >> 6951197

Molecular genetics of vaccinia virus: demonstration of marker rescue.

E Nakano, D Panicali, E Paoletti.   

Abstract

Two genomic variants of vaccinia virus isolated from serially propagated stocks were used to demonstrate marker rescue. The smaller (S variant) virus contains a 6.3 megadalton (MDal) deletion of unique DNA sequences present in the 123-MDal larger (L variant) virus. The deletion was mapped at 6.85 MDal from the left terminus of the genome, just outside of the inverted terminal repetition. Rescue of the unique deleted DNA sequences by infectious S variant virus was obtained in CV-1 cells by using the calcium orthophosphate precipitation technique of intact or restriction endonuclease-treated L-variant DNA. Restriction fragments that overlapped the deletion allowed marker rescue, but restriction of the L-variant DNA within the unique deleted sequences gave negative results. Restriction endonuclease analysis of the DNA obtained from twice-plaque-purified recombinant virus derived from the rescue of overlap donor fragments gave a restriction pattern identical to that of L-variant virus, indicating that the donor DNA was inserted into the rescuing virus by double recombination. No amplification of the unique sequences was observed from intact L-variant DNA in the absence of infectious S-variant virus, suggesting that deproteinized vaccinia DNA is noninfectious and that the donor DNA was neither integrated into the host DNA nor present as an episomal structure. By using 1 microgram of intact L-variant DNA per CV-1 monolayer in a 6-cm Petri dish, approximately 1--5% of the plaques contained the L-variant genotype, and the dose--response curve was essentially linear from 0.1 to 2 microgram of DNA.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6951197      PMCID: PMC346021          DOI: 10.1073/pnas.79.5.1593

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  22 in total

1.  The genetic map of bacteriophage phiX174 constructed with restriction enzyme fragments.

Authors:  P J Weisbeek; J M Vereijken; P D Baas; H S Jansz; G A Van Arkel
Journal:  Virology       Date:  1976-07-01       Impact factor: 3.616

2.  The structure and biological properties of herpes simplex virus DNA.

Authors:  N M Wilkie; J B Clements; J C Macnab; J H Subak-Sharpe
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

3.  Mapping the genes of simian virus 40.

Authors:  C J Lai; D Nathans
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1975

4.  Construction of the genetic map of the polyoma genome.

Authors:  L K Miller; M Fried
Journal:  J Virol       Date:  1976-06       Impact factor: 5.103

5.  Mapping temperature-sensitive mutants of simian virus 40: rescue of mutants by fragments of viral DNA.

Authors:  C J Lai; D Nathans
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

6.  Deletion mutants of simian virus 40 generated by enzymatic excision of DNA segments from the viral genome.

Authors:  C J Lai; D Nathans
Journal:  J Mol Biol       Date:  1974-10-15       Impact factor: 5.469

7.  A new technique for the assay of infectivity of human adenovirus 5 DNA.

Authors:  F L Graham; A J van der Eb
Journal:  Virology       Date:  1973-04       Impact factor: 3.616

Review 8.  The genetics of animal viruses.

Authors:  F Fenner
Journal:  Annu Rev Microbiol       Date:  1970       Impact factor: 15.500

9.  A membrane-filter technique for the detection of complementary DNA.

Authors:  D T Denhardt
Journal:  Biochem Biophys Res Commun       Date:  1966-06-13       Impact factor: 3.575

10.  Genetic assay for small fragments of bacteriophage phi X174 deoxyribonucleic acid.

Authors:  C A Hutchison; M H Edgell
Journal:  J Virol       Date:  1971-08       Impact factor: 5.103

View more
  47 in total

1.  Clustered charge-to-alanine mutagenesis of the vaccinia virus H5 gene: isolation of a dominant, temperature-sensitive mutant with a profound defect in morphogenesis.

Authors:  J DeMasi; P Traktman
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Genetic evidence for involvement of vaccinia virus DNA-dependent ATPase I in intermediate and late gene expression.

Authors:  M S Künzi; P Traktman
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

3.  In vitro resolution of poxvirus replicative intermediates into linear minichromosomes with hairpin termini by a virally induced Holliday junction endonuclease.

Authors:  D Stuart; K Ellison; K Graham; G McFadden
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

4.  Utilization of DNA recombination for the two-step replacement of growth factor sequences in the vaccinia virus genome.

Authors:  D D Spyropoulos; V Stallard; B E Roberts; L K Cohen
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

5.  Cloning and expression of foreign genes in vaccinia virus, using a host range selection system.

Authors:  M E Perkus; K Limbach; E Paoletti
Journal:  J Virol       Date:  1989-09       Impact factor: 5.103

6.  Two types of deletions in orthopoxvirus genomes.

Authors:  S N Shchelkunov; A V Totmenin
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

Review 7.  Reflections on the early development of poxvirus vectors.

Authors:  Bernard Moss
Journal:  Vaccine       Date:  2013-04-10       Impact factor: 3.641

8.  Effect of marker distance and orientation on recombinant formation in poxvirus-infected cells.

Authors:  R J Parks; D H Evans
Journal:  J Virol       Date:  1991-03       Impact factor: 5.103

9.  General method for production and selection of infectious vaccinia virus recombinants expressing foreign genes.

Authors:  M Mackett; G L Smith; B Moss
Journal:  J Virol       Date:  1984-03       Impact factor: 5.103

10.  Construction of live vaccines using genetically engineered poxviruses: biological activity of vaccinia virus recombinants expressing the hepatitis B virus surface antigen and the herpes simplex virus glycoprotein D.

Authors:  E Paoletti; B R Lipinskas; C Samsonoff; S Mercer; D Panicali
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.